Archive · 21 Jan 2026
India Advances Breast Cancer Screening
Breast cancer screening has traditionally been based on age, but new research shows that tailoring screening to individual risk factors, like family history and genetics, can be just as effective.
In India, where breast cancer is often diagnosed at a younger age, this approach could be a game-changer.
Instead of trying to fit a 40-year-old system, India has the chance to build a new, more efficient model from scratch.
This model could use existing health workers, digital tracking, and genetic data to make sure women get the right screening at the right time.
The recent WISDOM study has shown that this risk-adapted screening is feasible and safe, giving India a unique opportunity to leapfrog in breast cancer care.
Additionally, new advanced MRI-guided biopsy tools are being introduced to detect cancers that might be missed by traditional mammography, especially in women with dense breast tissue.
Traditional age-based mammography is being challenged by risk-adapted screening, which tailors screening to individual risk factors.
The WISDOM trial found risk-based screening to be feasible, acceptable, and clinically sound, with comparable detection of advanced cancers.
India's median age for breast cancer diagnosis is 47, younger than in Western countries, making traditional mammography less effective.
India has the opportunity to design a risk-adapted screening model from scratch, leveraging existing health infrastructure and digital initiatives.
The Genome India Project and National Cancer Grid can support the development and implementation of targeted, risk-based screening in India.
- Who
- Women in India, particularly those aged 40-74
- What
- Shift from traditional age-based mammography to risk-adapted breast cancer screening and advanced diagnostic tools
- When
- Ongoing, with recent results from the WISDOM trial published in December 2025 and new diagnostic tools launched recently
- Where
- India, with potential global implications
- Why
- To improve early detection and efficiency of breast cancer screening, tailored to individual risk factors and addressing the limitations of traditional mammography
- Mammography Impact
- Reduced mortality by 25–30% in women aged 50-69
- WISDOM Trial
- Compared traditional mammography with risk-adapted screening
- Risk-Adapted Screening
- Tailors screening based on individual risk factors
- Median Age in India
- 47 years at diagnosis, younger than Western countries
- Screening Rates in India
- 0.9% clinical breast exams, 1.3% mammograms in women aged 45+
- WHO Recommendation
- Prioritize early-diagnosis pathways and targeted screening
- Genome India Project
- Aims to develop breast-cancer risk models based on Indian genetic data
- National Cancer Grid
- Provides quality standards and referral pathways for cancer care
- MRI-guided VABB
- Advanced technique for detecting breast cancer in dense breast tissue
- Breast Cancer Prevalence
- 27-28% of all cancers among Indian women
